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Abstract
Background:  Moraxella catarrhalis causes approximately 10% of exacerbations in chronic
obstructive pulmonary disease (COPD) and also colonizes the lower airway in stable patients. Little
is known about the effects of colonization by M. catarrhalis on airway inflammation and protease-
antiprotease balance, and how these changes compare to those seen during exacerbations. Since
COPD is a progressive inflammatory disease, elucidating the effects of bacterial colonization and
exacerbation on airway inflammation is relevant to understanding disease progression in COPD.
Our aims were (1) Analyze changes in airway inflammation in colonization and exacerbation of
COPD due to M. catarrhalis; (2) Explore protease-antiprotease balance in colonization and
exacerbation due to M. catarrhalis. Our hypothesis were (1) Acquisition of a new strain of M.
catarrhalis in COPD increases airway inflammation from baseline and alters the protease-
antiprotease balance towards a more proteolytic environment; (2) These changes are greater
during exacerbations associated with M. catarrhalis as compared to colonization.
Methods: Thirty-nine consecutive COPD patients with 76 acquisitions of a new strain of M.
catarrhalis over a 6-year period were identified in a prospective study. Seventy-six pre-acquisition
sputum supernatant samples, obtained just before acquisition of M catarrhalis, and 76 acquisition
samples (34 were associated with exacerbation, 42 with colonization) were analyzed for IL-8, TNF-
α, Neutrophil Elastase (NE) and Secretory leukocyte protease inhibitor (SLPI). Changes were
compared in paired samples from each patient.
Results:  IL-8, TNF-α and NE were significantly elevated after acquisition of M. catarrhalis,
compared to pre-acquisition samples (p =< 0.001 for all three). These changes were present in
colonization (p = 0.015 for IL-8; p =< 0.001 for TNF-α and NE) as well as in exacerbation (p =<
0.001 for all three), compared to pre-acquisition levels. SLPI was significantly lower after acquisition
(p =< 0.001), in colonization (p =< 0.001) as well as in exacerbation (p = 0.004), compared to pre-
acquisition levels. SLPI levels correlated negatively with NE levels (R2 = 0.07; p = 0.001).
Published: 15 November 2009
BMC Infectious Diseases 2009, 9:178 doi:10.1186/1471-2334-9-178
Received: 10 May 2009
Accepted: 15 November 2009
This article is available from: http://www.biomedcentral.com/1471-2334/9/178
© 2009 Parameswaran et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
Page 2 of 10
(page number not for citation purposes)
Conclusion: Acquisition of M. catarrhalis in COPD causes increased airway inflammation and
worsening protease-antiprotease imbalance during exacerbations and also in colonization, even in
the absence of increased symptoms. These effects could contribute to progression of airway
disease in COPD.
Background
Chronic obstructive pulmonary disease (COPD) is charac-
terized by chronic airway inflammation, and progressive
deterioration in lung function and general health status
[1-4]. The course of COPD is punctuated by acute exacer-
bations, which are characterized by worsening respiratory
symptoms, enhanced airway inflammation [5,6] and
deterioration of lung function [7]. A variety of airway
inflammatory mediators and cells increase with exacerba-
tion, reflecting mainly neutrophilic and at times eosi-
nophilic inflammation [4-8].
Approximately half of COPD exacerbations are caused by
bacterial pathogens including nontypeable Haemophilus
influenzae, Moraxella catarrhalis, Streptococcus pneumoniae
and Pseudomonas aeruginosa [9-12]. These same pathogenic
bacteria can be found in the lower airways of 30%-40% of
COPD patients in the absence of symptoms of an acute
exacerbation. This 'colonization' by potential pulmonary
pathogens is also associated with increased airway inflam-
mation; however these observations have been confined
to cross-sectional studies [13-15]. During exacerbations of
COPD, symptoms correlate with the level of airway
inflammation [5,16,17]. Therefore, one would expect air-
way inflammation induced by colonization to be of lower
intensity than that observed during an exacerbation.
However, a direct comparison between airway inflamma-
tion associated with colonization and exacerbation in the
same patient population has not been described.
Furthermore, previous studies of bacteria-associated
inflammation in COPD, during colonization or exacerba-
tion, have included several different bacterial pathogens.
It is likely that the inflammatory response in the airways
in COPD to different bacterial species is different. Study-
ing the inflammatory response to a single pathogenic spe-
cies is likely to be more consistent and allow one to better
compare colonization with exacerbation.
An enduring hypothesis is that tissue damage in COPD is
due to an imbalance between proteases, produced mostly
by neutrophils and macrophages, and anti-proteases pro-
duced locally in the airways as well as transudating from
plasma [18]. This imbalance is worsened during exacerba-
tions of COPD [8,17]. Neutrophil elastase (NE) is the pro-
tease most implicated in causing tissue damage in COPD.
SLPI is the main anti-protease in airway secretions
[18,19]. The balance between NE and SLPI is altered in a
detrimental way, tilting the balance toward proteolytic
activity, during exacerbations [8]. Whether colonization
by potential pulmonary pathogenic bacteria, without any
change in baseline respiratory symptoms, can alter the
protease-antiprotease balance in the airways is unknown.
We decided to study the effects of acquisition of patho-
genic bacteria in COPD patients by individual bacterial
species in order to minimize the variability in host
response to different bacterial species. M. catarrhalis dem-
onstrates well-defined periods of carriage in COPD and
causes approximately 10% of acute exacerbations in
COPD [12]. Therefore, we chose M. catarrhalis as the index
pathogen in this study. Our hypothesis was that acquisi-
tion of a new strain of M. catarrhalis in COPD enhances
airway inflammation from baseline and alters the pro-
tease-antiprotease balance towards a more proteolytic
environment. We further hypothesize that these changes
are greater during exacerbations associated with M.
catarrhalis as compared to colonization by this pathogen.
Methods
COPD study clinic
Details of this study clinic have been described previously
[5,11]. The Institutional Review Board of the VA WNY
Healthcare system approved the study protocol. All partic-
ipants gave written informed consent. Briefly, participants
with smoking associated chronic bronchitis were enrolled
and followed on a monthly basis and also whenever they
suspected they were experiencing an exacerbation. At each
clinic visit, clinical information, sputum and serum sam-
ples were collected. Patients were questioned about the
status of their chronic respiratory symptoms (dyspnea,
cough, sputum production, viscosity and purulence), and
the responses were graded at 1 (at the usual level), 2
(somewhat worse than usual) or 3 (much worse than
usual). A minor worsening of two or more symptoms or
major worsening of one or more symptoms prompted
clinical assessment of the cause. If the patient had fever
(>38.3C), appeared ill or had signs of consolidation on
examination of the lungs, a chest film was obtained to
rule out pneumonia. If other causes of worsening of
symptoms, such as pneumonia, upper respiratory tract
infection, or congestive cardiac failure were ruled out, the
patients was considered to be having an exacerbation of
COPD. The determination of whether the patient had sta-
ble disease or an exacerbation was made before results of
sputum cultures were available [5,11].BMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
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Acquisition was defined as the isolation of new strain of
M. catarrhalis from sputum culture in a patient who did
not have the same strain on sputum cultures previously.
New strains were identified by pulsed field gel electro-
phoresis [12]. Colonization was defined as acquisition of
a new strain of M catarrhalis, but with no change in base-
line respiratory symptoms.
Sputum Samples
Sputum samples were processed as described previously
[5,11]. Briefly, spontaneously expectorated morning spu-
tum samples were homogenized with the addition of
dithiothreitol (Sputolysin, Calbiochem USA) and an aliq-
uot processed for quantitative bacteriology. Sputum
supernatants were obtained by centrifugation and stored
at -80 degrees C.
During the period 1994-2000, a total of 50 patients
acquired a new strain of M catarrhalis for a total of 120
acquisitions [12]. Of these, 57 (47.5%) acquisitions were
associated with exacerbation, the rest 63 (52.5%) were
colonization episodes in which no change in baseline
symptoms occurred. Sputum samples obtained at the
time of new strain acquisition (acquisition samples) as
well as those obtained at a visit prior to the acquisition of
M. catarrhalis (pre-acquisition samples), were identified.
If an acquisition sample was not available, the corre-
sponding pre-acquisition samples were also not included
in this study. Pre-acquisition samples were obtained at a
clinically stable state. Available samples closest to the
acquisition sample were used.
Sputum analysis
Sputum supernatant levels of interleukin-8 (IL-8), tumor
necrosis factor (TNF-α) and active neutrophil elastase
(NE) were measured as described earlier [5]. Secretory leu-
kocyte protease inhibitor (SLPI) levels in sputum were
measured by sandwich ELISA as follows. Ninety six-well
plates (Corning, USA) were coated with 100 μl/well of
monoclonal anti- human SLPI antibody (R&D Systems,
Minneapolis, MN, USA) diluted to 2 μg/ml in 0.1 M
sodium carbonate/0.1 M sodium bicarbonate buffer (pH
9.6) overnight at 4°C. Wells were blocked with 300 μl/
well of 3% milk powder in PWB (1× Phosphate buffered
saline with 0.05% Tween-20) for 1 hour at room temper-
ature. Washing with PWB in between incubations, 100 μl
volumes of standards (recombinant human SLPI, R&D
Systems, Minneapolis, MN, USA) and samples (diluted
1:10,000 in 1% milk powder/PWB), were added to the
wells for 37°C for 2 hours, followed by biotinylated anti-
human SLPI antibody (R&D Systems, Minneapolis, MN,
USA) diluted to 10 ng/ml in 1% milk powder/PWB, 100
μl/well for 1 hour at room temperature, followed by 100
μl/well of HRP labeled Streptavidin (Kirkegaard & Perry
Laboratories, Gaithersburg, MD, USA) diluted 1:10,000 in
3% goat serum/PWB for 30 minutes at room temperature.
Color development was done with Tetra-methyl benzi-
dine (TMB) dissolved in Dimethyl sulfoxide (DMSO) at
room temperature in dark for 15 minutes. The reaction
was stopped by adding 100 μl/well of 1 M H2SO4. Absorb-
ance at 450 nM was determined and SLPI levels in the
sample wells were determined from the standard curve.
The minimum concentration of SLPI detectable in this
assay was 0.1 nanograms/ml and the linear range was 0.5-
10 ng/ml.
Statistical analysis
Data are presented as mean ± standard error (SEM) when
normally distributed and as median ± interquartile range
when non-normally distributed. Analyses were performed
for paired data by comparing pre-acquisition and acquisi-
tion samples. Changes in log-transformed IL-8, TNF-α,
NE and SLPI were compared with paired t-tests. Non-nor-
mally distributed paired data were analyzed with Wil-
coxon paired rank sum tests. Comparisons between
changes in colonization and exacerbation were done with
Student 't' test. Correlation between NE and SLPI was
assessed with linear regression. Statistical analyses were
conducted using Analyse-it® and Microsoft Excel®.
Results
Samples and Subjects
Out of a total of 120 M. catarrhalis new strain acquisitions
during the period 1994-2000, 76 acquisition samples
were available for analysis. The rest of the acquisition
samples (44) had been used up in prior studies examining
other aspects of M. catarrhalis in COPD. Each acquisition
sputum sample, from which a new strain of M. catarrhalis
was first isolated from a patient, was paired with a pre-
acquisition sample from the same patient. A total of 76
such paired sputum samples from 39 patients were avail-
able for analysis, of which 34 (44.7%) acquisitions were
associated with exacerbation, while 42 (55.3%) were col-
onization episodes. In the pre-acquisition samples, no
potentially pathogenic bacteria were cultured from spu-
tum. In the acquisition samples, M. catarrhalis was the
only potentially pathogenic bacterial species found on
sputum culture. There were 104 subjects who had at least
one COPD study clinic visit during 1994-2000. Of these,
39 subjects contributed samples to this study and their
demographics are shown in Table 1. The mean time
between pre-acquisition and acquisition samples was 1.9
months (95% CI 1.6-2.3); median time between was 1
month (95% CI 1-2).
Change in airways inflammation with M. catarrhalis 
acquisition
We measured sputum IL-8 and TNF-α to determine
whether acquisition of M catarrhalis changes levels of air-
way inflammation. Baseline airway inflammation varies
among patients with COPD. Therefore, all analyses were
performed for paired data by comparing pre-acquisitionBMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
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and acquisition samples. In order to accurately measure
the change in airway inflammation with acquisition,
changes in log transformed values of the inflammatory
markers were calculated by subtracting the pre-acquisition
level from the acquisition level for each pair of samples (n
= 76 pairs). Significant increase in IL-8 [2.63 ng/ml (2.11
ng/ml to 4.74 ng/ml) p < 0.0001] and TNF-α [0.05 ng/ml
(0 ng/ml to 0.05 ng/ml) p < 0.0001] were seen with the
acquisition of M. catarrhalis (Table 2).
We analyzed the data further to determine whether airway
inflammation increases with colonization by M. catarrha-
lis, and to compare these changes with those seen with
exacerbation. Colonization with M. catarrhalis was associ-
ated with significant increases from baseline in the levels
of IL-8 (p = 0.015) and TNF-α (p =< 0.001). Exacerbations
were associated with larger increases in airway inflamma-
tion than colonization (Table 3, Fig 1, 2). This increase
from pre-acquisition levels was significantly larger in exac-
erbation, compared to the increase in colonization, for IL-
8 (p = 0.012), but not for TNF-α (p = 0.197). We conclude
that acquisition of a new strain of M. catarrhalis increases
airway inflammation in COPD. This increase is seen with
colonization by M. catarrhalis and to a larger extent during
exacerbations.
Protease-antiprotease balance and M. catarrhalis 
acquisition
SLPI is a major anti-protease in the airway lumen, while
NE reflects uninhibited protease activity. We assessed
changes in airway protease- antiprotease balance with
acquisition of M. catarrhalis, by determining changes from
baseline in NE and SLPI. With acquisition of M. catarrha-
lis, NE levels increased [8.3 nM/ml (0.12 nM to 8.42 nM),
p < 0.0001] while SLPI levels decreased significantly [-
24.76 μg/ml (35.6 μg to 10.84 μg) p =< 0.001] (Table 2).
SLPI and NE levels had an inverse correlation by linear
regression analysis (R2 = 0.07; p = 0.001 for the slope)
(Fig. 3).
We analyzed the data further to determine whether pro-
tease-antiprotease balance changes with colonization by
M. catarrhalis, and to compare these changes with those
seen with exacerbation. Colonization as well as exacerba-
tion samples had significantly higher levels of NE and
lower levels of SLPI, when compared to pre-acquisition
samples (Table 3). The increase in NE from pre-acquisi-
tion levels was significantly higher in exacerbation as
compared to the increase in colonization (p = 0.01, Fig.
4); while the decrease in SLPI from pre-acquisition levels
was not significantly different between colonization and
exacerbation (p = 0.7; Fig. 5). The relation between NE
and SLPI, analyzed separately in exacerbation and coloni-
zation by linear regression, showed inverse relationships,
but without reaching significance (Figures 6 and 7).
We conclude that acquisition of a new strain of M. catarrh-
alis is associated with worsening protease-antiprotease
balance in favor of protease activity, and this occurs in col-
onization, albeit to a lesser extent than in exacerbations
due to M. catarrhalis.
Inter-relationship of airway inflammation and 
changes in NE
A positive correlation between sputum levels of IL-8 and
NE has been described in bacterial exacerbations of COPD
[17]. In an effort to understand whether airway inflamma-
tion is related to protease-antiprotease balance in coloni-
Table 1: Patient characteristics
Mean age in years (range) 65.9 (46-81)
Gender Male:38; Female:1
Race Caucasian:32; African-American:7
Mean years since diagnosis (range) 12.5(0-54)
Smoking status on enrollment Current: 13; Ex-smokers:26
Mean smoking pack years (range) 76.3(10-175)
Mean FEV1 in liters (range) 1.62(0.47- 4.07)
Mean FEV1% predicted (range) 47.4(15-99)
GOLD severity (number in each group) 0 = 2; 1 = 1; 2 = 12; 3 = 18; 4 = 6
Table 2: Levels of IL-8, TNF-α, NE and SLPI in sputum supernatants before and with acquisition of M catarrhalis (p values by Wilcoxon 
matched pairs rank test).
Pre-acquisition Median
(Interquartile range)
Acquisition Median
(Interquartile range)
p value
IL-8 ng/ml 2.11 (5.09) 4.74 (17.5) <0.001
TNF-α ng/ml 0 (0.02) 0.05 (0.15) <0.001
NE nM/ml 0.12 (0.2) 8.42 (76.55) <0.001
SLPI μg/ml 35.6 (47.75) 10.84 (24.19) <0.001BMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
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zation by M. catarrhalis, we analyzed our data using linear
regressions. This shows that sputum levels of IL-8 and
TNF-α, which are markers of airway inflammation, corre-
late positively with levels of NE in colonization samples
(Figs 8, 9). We conclude that airway inflammation in col-
onization due to M. catarrhalis correlates with changes in
protease-antiprotease balance.
Discussion
When COPD patients acquire a new strain of M. catarrha-
lis, approximately 50% suffer an acute exacerbation, and
these exacerbation episodes are associated with a signifi-
cant increase in neutrophilic airway inflammation from
baseline [5,12]. The significance of colonization by M.
catarrhalis in relation to airway inflammation in COPD
and progression of disease was unclear. Though earlier
cross-sectional studies had demonstrated that such colo-
nization by bacterial pathogens, including M. catarrhalis,
is pro-inflammatory, these studies lacked baseline values
prior to acquisition of M. catarrhalis to determine accu-
Table 3: Changes in log10 levels of IL-8, TNF-α, NE and SLPI from pre-acquisition to acquisition, colonization and exacerbation 
samples. (p values by comparison to pre-acquisition levels by t test)
Acquisition-
Mean change (95% CI)
n = 76
Colonization samples only
Mean change (95% CI)
n = 34
Exacerbation samples only
Mean change (95% CI)
n = 42
Change in IL-8 0.39 (0.25-0.53)
(p =< 0.001)
0.23 (0.04-0.42)
(p = 0.015)
0.59 (0.38-0.79)
(p =< 0.001)
Change in TNF-α 0.72 (0.48-0.96)
(p =< 0.001)
0.58 (0.31-0.85)
(p =< 0.001)
0.89 (0.47-1.33)
(p =< 0.001)
Change in Elastase 1.12 (0.79- 1.44)
(p =< 0.001)
0.74 (0.32-1.16)
(p =< 0.001)
1.58 (1.08-2.08)
(p =< 0.001)
Change in SLPI -0.51 (-0.72 to -0.30)
(p =< 0.001)
-0.47 (-0.72- -0.23)
(p =< 0.001)
-0.55 (-0.92- -0.19)
(p = 0.004)
Log10 change from IL-8 pre-acquisition levels for colonization  and exacerbation samples (Box-plots showing means and  95% CI); c = colonization; e = exacerbation Figure 1
Log10 change from IL-8 pre-acquisition levels for col-
onization and exacerbation samples (Box-plots show-
ing means and 95% CI); c = colonization; e = 
exacerbation.
Log10 change from TNF-α pre-acquisition levels for coloniza- tion and exacerbation samples (Box-plots showing means  and 95% CI); c = colonization; e = exacerbation Figure 2
Log10 change from TNF-α pre-acquisition levels for 
colonization and exacerbation samples (Box-plots 
showing means and 95% CI); c = colonization; e = 
exacerbation.BMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
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rately the change in inflammation associated with such
colonization. The present study clearly demonstrates that
colonization by M. catarrhalis is associated with enhanced
airway inflammation, and that such inflammation is of
lesser intensity than that seen in exacerbations associated
with this pathogen. These findings imply that coloniza-
tion by M. catarrhalis could contribute to tissue damage
and disease progression in COPD.
Proteases play a major role in the disease progression in
COPD, and any stimulus that enhances the proteolytic
environment in the airways in COPD is likely to be detri-
mental and may contribute to disease progression. Previ-
ous studies have demonstrated that NE activity is
increased during exacerbations of COPD, while SLPI level
declines, thereby shifting the airway lumen environment
towards proteolysis [8,17]. Our data extends these obser-
vations to colonization by M. catarrhalis, a finding that
has important implications for progressive tissue damage
in COPD.
The mechanisms underlying the reciprocal relationship
between NE and SLPI are not fully understood, but there
are several studies that suggest inactivation or degradation
of SLPI by proteases. Studies with airway epithelial cell
cultures show that exposure to NE increased mRNA
expression for SLPI in these cells [20,21]. Immunohisto-
chemistry demonstrated presence of SLPI in these cells
[22]. However, in spite of increased production of SLPI
induced by NE, cell supernatants in these experiments
contained less SLPI compared to non-exposed cells
[20,22,23]. This observation suggests extracellular
destruction of SLPI. Several proteases, including NE,
cathepsins and bacterial proteases can degrade SLPI in-
vitro [24,25]. Another recently described potential mech-
anism of depletion of SLPI from respiratory secretions is
adherence of SLPI-NE complexes to negatively charged
membranes, including cell membranes [26]. It is not
known whether M. catarrhalis has any direct down-regu-
lating effect on SLPI production; this is an area for future
investigation.
While we have considered airway inflammation and pro-
tease-antiprotease balance separately in results, it is highly
likely that these are inter-related. IL-8 is a known chemo-
attractant for neutrophils which produce NE [27,28].
Linear regression showing relationship of log-SLPIand log-NE  levels for all samples (acquisition and pre-acquisition samples  included) (R2 = 0.07; p = 0.001) Figure 3
Linear regression showing relationship of log-SLPI-
and log-NE levels for all samples (acquisition and pre-
acquisition samples included) (R2 = 0.07; p = 0.001).
Log10 change from NE pre-acquisition levels for colonization  and exacerbation samples (Box-plots showing means and  95% CI); c = colonization; e = exacerbation Figure 4
Log10 change from NE pre-acquisition levels for colo-
nization and exacerbation samples (Box-plots show-
ing means and 95% CI); c = colonization; e = 
exacerbation.BMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
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Prior studies have shown that IL-8 levels in airway secre-
tions correlate positively with NE levels in patients with
chronic bronchitis during stable state and during exacer-
bations [4,8,17]. We extend these observations to coloni-
zation by M. catarrhalis as well.
Whether the changes we describe with colonization are
specific to M. catarrhalis or present with other pathogenic
bacteria as well is not clear at present. Many outer mem-
brane components of M. catarrhalis trigger humoral
immune responses [29,30] and probably are involved in
triggering the inflammatory response in airways of COPD
patients. M. catarrhalis activates NF-κB and MAPK path-
ways for increased production of inflammatory cytokines
[31]. Moreover, M catarrhalis reduces the activity of his-
tone deacetylase enzymes, promoting acetylation and eas-
ier access for the transcription factors like NF-kB to the
genes for inflammatory cytokines like IL-8 [31]. Reduc-
tion of histone deacetylase activity is seen in COPD [32],
suggesting that infection by bacteria such as M. catarrhalis
could contribute to the dysregulated inflammation in
COPD by this pathway. Additional studies to elucidate
specific components of M. catarrhalis and pathways
involved will lead to better understanding of bacteria-
induced inflammation in COPD.
Limitations of this study are that sputum samples were
not studied for neutrophil counts, viral and atypical bac-
terial pathogens, eosinophilic and other cellular inflam-
mation. Neither did we examine indices of systemic
inflammation in these episodes of M catarrhalis acquisi-
tion. We have examined only one protease present in
human airways, though it is the major one (NE) and only
one of the anti-proteases (SLPI). Other proteases such as
matrix metalloproteases and anti-proteases such as a-1
antiprotease and elafin may play significant roles in colo-
nization and exacerbation. Since our COPD clinic is based
at a VA facility, almost all our patients are males. Our
clinic recruits patients with smoking-induced chronic
bronchitis with or without emphysema. Hence our find-
ings may not be applicable to patients with pure emphy-
sema alone. We have not examined long-term
implications with regards to changes in lung function and
functional status.
Co-existent viral infection could have contributed to the
inflammation seen during colonization and exacerbation
episodes with M. catarrhalis. However, we have earlier
demonstrated that large increases in neutrophilic airway
Log10 change from SLPI pre-acquisition levels for colonization  and exacerbation samples (Box-plots showing means and  95% CI); c = colonization; e = exacerbation Figure 5
Log10 change from SLPI pre-acquisition levels for col-
onization and exacerbation samples (Box-plots show-
ing means and 95% CI); c = colonization; e = 
exacerbation.
Linear regression showing relationship of log-SLPI and log- NE levels for exacerbation samples only (R2 = 0.1; p = 0.06) Figure 6
Linear regression showing relationship of log-SLPI 
and log-NE levels for exacerbation samples only (R2 = 
0.1; p = 0.06).BMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
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inflammation are characteristic of new bacterial strain
acquisition [5]. Colonization episodes by definition were
not associated with symptoms of respiratory infection,
making a concomitant acute viral infection when these
samples were collected unlikely. Though examining a sin-
gle pathogen species in this study had several advantages,
it does limit our ability to generalize these results to other
bacterial pathogens in COPD.
We chose to study sputum rather than bronchoalveolar
lavage (BAL) as repeated sampling using bronchoscopy
would be invasive and paired pre-acquisition and acquisi-
tion samples would have been difficult to obtain. Though
BAL cultures are more representative of lower airway bac-
teriology, we have shown in a prior study that sputum
obtained with the protocol used in our study clinic
approximates closely to induced sputum, and has the
molecular markers of lower airway secretions [9].
Conclusion
In conclusion, M. catarrhalis acquisition in COPD, with or
without symptoms of exacerbation, is potentially detri-
mental to the course of COPD by enhancing airway
Linear regression showing relationship of log-SLPI and log- NE levels for colonization samples only (R2 = 0.02; p = 0.43) Figure 7
Linear regression showing relationship of log-SLPI 
and log-NE levels for colonization samples only (R2 = 
0.02; p = 0.43).
Linear regression showing relationship of log-IL-8 and log-NE  levels for colonization samples only (R2 = 0.38; p =< 0.001) Figure 8
Linear regression showing relationship of log-IL-8 
and log-NE levels for colonization samples only (R2 = 
0.38; p =< 0.001).
Linear regression showing relationship of log-TNF-α and log- NE levels for colonization samples only (R2 = 0.38; p =<  0.001) Figure 9
Linear regression showing relationship of log-TNF-α 
and log-NE levels for colonization samples only (R2 = 
0.38; p =< 0.001).BMC Infectious Diseases 2009, 9:178 http://www.biomedcentral.com/1471-2334/9/178
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inflammation and worsening protease-antiprotease
imbalance.
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